JPND Research

What JPND Research does

JPND Research (EU Joint Programme – Neurodegenerative Disease Research) is the largest global research initiative aimed at tackling neurodegenerative diseases, established in April 2010 in Stockholm as the first EU Joint Programming Initiative in health research. The organization coordinates transnational research across 25 European countries, aligning scientific competencies, research funding, and infrastructure to address fragmentation and duplication in neurodegenerative disease research. JPND's core offering is a coordinated suite of research support services, including annual transnational funding calls for proposals (with combined country-level budgets such as the €19 million 2012 Risk Factors call), data infrastructure resources (the Research Database, the Global Cohort Portal, and Experimental Models for Parkinson's Disease), annual scientific symposia, and strategic frameworks including research mapping exercises and a monitoring and evaluation framework. It also operates the Network of Centres of Excellence (CoEN) for cross-border collaboration with Canada, the UK, and Germany.

The underlying technology platform functions as a research coordination and data hub rather than a commercial software product. Proprietary features include the JPND Global Cohort Portal (a portal for accessing global cohort data), the searchable Research Database (covering programmes, grants, and infrastructure across member countries), and a repository of Experimental Models for Parkinson's Disease. These assets are differentiated on scale and interoperability, enabling researchers across borders to share data and infrastructure. The JUMPAHEAD coordination action (2010-2014, €2 million FP7 grant) established the Strategic Research Agenda, which was refreshed as the 2019 Research and Innovation Strategy in 2018. Three EU Horizon 2020 grant agreements (No. 643417, No. 681043, No. 825664) have funded ongoing coordination activities.

JPND does not operate a commercial business model. It is publicly funded through EU framework programme grants and national contributions from participating member states' research funding agencies (including INSERM, MRC, BMBF, HRB, ZonMw, MIUR, TUBITAK, and ISCIII). The organization has 1-10 employees and is coordinated from Dublin, Ireland, through the Health Research Board. Governance is provided by a Management Board chaired by Professor Philippe Amouyel, advised by a 15-member Scientific Advisory Board chaired by Professor Thomas Gasser. Customer-facing segments include European research institutions and universities (primary), national funding agencies, and individual researchers, clinicians, and patient groups seeking access to coordinated research infrastructure.

Name

JPND Research

Legal name

JPND Research

Website

https://neurodegenerationresearch.eu

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

JPND Research (EU Joint Programme – Neurodegenerative Disease Research) is the largest global research initiative tackling neurodegenerative diseases, coordinating transnational funding calls, shared research infrastructure, and symposia across 25 European countries.

Ownership category

akta.pro rank

Product category

Biomedical Research Coordination

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Research & Science Grantmaking Foundations (BPAGAKAI), Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB), Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

Keywords

• Neurodegenerative disease research
• Transnational research coordination
• Biomedical research funding
• Research consortium management
• Cohort data portal

Headquarters

HQ city

Dublin

HQ country

Ireland

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others

Marketing channels7 records

Core offering

JPND Research is a publicly funded, non-commercial research coordination initiative that facilitates transnational collaboration on neurodegenerative disease research across 25 European countries. It operates annual joint funding calls with national funding agencies, expert working groups, symposia, and shared research infrastructure including the JPND Research Database, Global Cohort Portal, Experimental Models for Parkinson's Disease catalogue, the CoEN (Network of Centres of Excellence in Neurodegeneration) co-funded calls, a Research Mapping exercise, and a Monitoring and Evaluation Framework.

Product overview

JPND Research is the largest global research initiative aimed at tackling neurodegenerative diseases. Rather than a single commercial product, JPND offers a coordinated suite of research support services including funding programs through annual transnational calls for proposals, data infrastructure resources (Research Database, Global Cohort Portal, Experimental Models), scientific convening through annual symposia, and strategic frameworks for monitoring, evaluation, and research mapping. The initiative coordinates across 25+ European countries and operates linked activities with partner organizations. The JUMPAHEAD coordination action (2010-2014) established the foundational Strategic Research Agenda, while ongoing activities include alignment actions, expert working groups, and network building through the Centres of Excellence initiative.

Differentiator

Problem solved

Functional benefit

Brands

• CoEN (Network of Centres of Excellence in Neurodegeneration): A collaborative initiative within JPND focused on building collaborative research activity across borders, bringing together national centres of excellence.

Products and services

• JPND Research Database Searchable online database that catalogues JPND-funded research projects and investigators, intended for use by the European neurodegenerative disease research community to identify existing work and collaborators.
• JPND Global Cohort Portal Online portal that links researchers to population-based cohorts relevant to ageing and neurodegeneration research across Europe, enabling cohort discovery and access for collaborative studies.
• Experimental Models for Parkinson's Disease Online catalogue/database of experimental (animal) models for Parkinson's Disease, made available to the European neurodegenerative disease research community for use in translational research.
• JPND Annual Calls for Proposals Annual joint transnational calls for research proposals on neurodegenerative diseases, co-funded by national funding agencies across JPND's participating countries, with which research groups can apply for co-funded transnational projects.
• JPND Research Mapping

Quantifiable outcome

• 25 European countries coordinating research strategies
• +2 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered minor, major and core.

• JPI More Years, Better LivesminorStrategic or Co-development Partner · 1 March 2015Joint Programming Initiative seeking to enhance coordination and collaboration between European and national research programmes related to demographic change, which encompasses neurodegenerative disease research given the strong link with aging.
• JPI A Healthy Diet for Healthy Life (HDHL)minorStrategic or Co-development Partner · 1 March 2015Joint Programming Initiative coordinating research in food, diet, physical activity and health. Under this umbrella, the joint action NutriCog addresses the interrelation of diet and cognitive function, relevant to neurodegenerative disease prevention.
• ERA-NET NEURONmajorStrategic or Co-development Partner · 1 January 2015ERA-NET NEURON is a network of ministries and funding organisations across Europe, Israel and Canada supporting basic, clinical and translational research in brain diseases. JPND recognizes NEURON as a linked activity for coordinated research efforts in neuroscience.
• World Dementia CouncilcoreStrategic or Co-development Partner · 1 December 2013The World Dementia Council was formed following the G8 Dementia Summit in December 2013. Prof. Philippe Amouyel, Chair of the JPND Management Board, is a member of the council. The council objectives are to speed up dementia research and increase investment with focus on integrated development, finance and incentives, and open science.
• CoEN (Network of Centres of Excellence in Neurodegeneration)coreStrategic or Co-development Partner · 1 June 2010CoEN is an independent but aligned initiative launched in June 2010 by CIHR (Canada), DZNE (Germany), and MRC (UK) to build collaborative research in neurodegeneration across borders. It operates as a separate entity from JPND but is recognized as relevant for tackling the global challenge of neurodegenerative diseases. CoEN has conducted multiple Pathfinder calls (2013, 2015, 2017) funding innovative research projects.
• JPND Member National Funding AgenciescoreStrategic or Co-development Partner25 European countries participate through their national funding agencies including: INSERM (France), MRC (UK), BMBF (Germany), HRB (Ireland), ZonMw (Netherlands), MIUR (Italy), TUBITAK (Turkey), ISCIII (Spain), and others. These agencies contribute to joint funding calls and align national research strategies with JPND objectives.
• JPND Scientific Advisory BoardcoreStrategic or Co-development PartnerA Scientific Advisory Board comprising 15 top neurodegenerative disease scientists from Europe and elsewhere advises on development and implementation of the Strategic Research Agenda. Members include key opinion leaders such as SAB Chair Professor Thomas Gasser.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• UK Dementia Research Institute (UK DRI): UK-based national institute dedicated to dementia and neurodegeneration research, co-funded by the MRC and charities. Comparable in scientific scope and KOL network to JPND's neurodegeneration mandate, though operating within a single country.
• ERA-NET NEURON: Network of European ministries and funding organisations supporting basic, clinical and translational research in brain diseases. Directly comparable to JPND as a transnational European neuroscience/brain-disease research coordination initiative, with overlapping funding-call and consortium-building models.
• DZNE (German Center for Neurodegenerative Diseases): Germany's national research centre for neurodegenerative diseases and a CoEN co-founder. Closely comparable to JPND in mission (neurodegeneration research) and partnership footprint, although it operates as a single national research institute rather than a transnational coordination platform.
• JPIAMR (Joint Programming Initiative on Antimicrobial Resistance): Another EU Joint Programming Initiative coordinating transnational research across member states. Highly structurally comparable to JPND in governance, funding-call design, and Horizon 2020/EU alignment, though focused on a different disease domain.

Regional players

• Canadian Institutes of Health Research (CIHR): Canada's primary federal health research funding agency and a CoEN co-founder alongside DZNE and MRC. Comparable as a neurodegeneration research funder and JPND partner, but geographically focused on Canada rather than pan-European coordination.

Broad incumbents

• Human Frontier Science Program (HFSP): International research funding programme supporting intercontinental life-science research. Comparable as a transnational, multi-country research-grant maker with a similar governance and peer-review model, though broader in scientific scope and geographically centred outside Europe.
• Alzheimer's Association: US-based nonprofit funding Alzheimer's and dementia research, advocacy, and care. Comparable as a leading funder of neurodegeneration research, with a much larger global donor base and advocacy footprint than JPND, but US-centric and nonprofit rather than intergovernmental.
• Innovative Health Initiative (IHI / former IMI): Large public-private partnership between the EU and life-science industry funding biomedical research. Comparable as a large European research-funding and consortium-building vehicle, but with much broader scope (including commercial industry partners) and far larger budgets than JPND.
• National Institutes of Health (NIH) – National Institute on Aging: US federal agency funding biomedical and behavioural research on ageing, including Alzheimer's and neurodegeneration. Comparable in neurodegeneration research-funding mission, though much larger in scale, US-focused, and operating as a primary research funder.

Emerging players

• JPI Healthy Diet for Healthy Life (JPI HDHL): A fellow EU Joint Programming Initiative coordinating research on diet, physical activity and health. Structurally comparable to JPND as a JPI with the same coordination/governance model and member-state footprint, but focused on a different research domain with only partial thematic overlap (e.g., NutriCog on diet and cognition).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/JPNDeurope
• YouTubeyoutube.com/user/jpndeurope/playlists
• LinkedInlinkedin.com/company/jpnd-joint-programme-neurodegenerative-disease-research

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JPND Research